摘要
目的观察自拟止痛Ⅰ号不同用药方式对晚期癌痛患者的止痛效果。方法将63例晚期癌痛患者随机分成对照组32例和观察组31例,均应用"止痛Ⅰ号",观察组采用静脉滴注(5~15滴/min),对照组采用止痛泵以2~5mL/h速度24h泵入。结果两组疼痛完全缓解率、显效率及不良反应发生率等比较均无显著性差异(P>0.05)。结论自拟止痛Ⅰ号能明显缓解晚期癌症患者的疼痛,以静脉滴注的给药方式更为理想。
Objective To observe the analgesic effect of Analgesic No. I to the advanced cancer patients by several administration ways. Methods 63 patients with advanced cancer were randomly divided into two groups: the control group and the observation group, the observation group was given Analgesic No. I by intravenous drip (5- 15 gtt/min). While the control group was given Analgesic No. I by analgesic pump with the rate of 2 - 5 mL/h. Results The two groups had no significant differences in the complete pain relieving rate, obvious effective rate and adverse reaction rate( P 〉 0. 05). Conclusion Analgesic No. I can obviously relieve pain in the advanced cancer patients, and the administration way of intravenous dripis is more ideal.
出处
《中国药业》
CAS
2009年第19期66-67,共2页
China Pharmaceuticals
关键词
癌症疼痛
止痛Ⅰ号
用药方式
cancer pain
Analgesic No.Ⅰ
administration